Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)
Clinical trial NCT04738292 · TERMINATED
Trial details
- NCT number
- NCT04738292
- Sponsor
- University of Wisconsin, Madison
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-05
- Primary completion
- 2023-04-03
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.